XETRA:DMP
Dermapharm Holding SE · XETRA · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 13:45 UTC
Last close
n/aEUR
Market data
15.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
10.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
11.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
12.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.52Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.43 against 0.57 on the market's range.
Follow one euro
lens 1 of 9After what it costs to make
33.6%
After running the business
19.0%
After interest and tax
11.4%
After what it must reinvest
12.0%
Kept after the dividend
7.8%
The five stops
5 of 5 read- After what it costs to make391,708,00033.6%
- After running the business221,748,00019.0%
- After interest and tax132,412,00011.4%
- After what it must reinvest139,394,00012.0%
- Kept after the dividend90,938,0007.8%
Of every unit of sales, 0.08 is still there after the dividend.
Of every unit of sales, 0.08 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales1,164,978,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
After what it costs to make391,708,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
After running the business221,748,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
After interest and tax132,412,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
After what it must reinvest139,394,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Kept after the dividend90,938,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR